CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq.Ed Korsinsky, Esq.33 Whitehall Street, 17th FloorNew York, NY 10004[email protected]Tel: (212) 363-7500Fax: (212) 363-7171www.zlk.com Accessibility StatementSkip Navigation NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Fly-E Group, Inc. ("Fly-E" or the "Company") (NASDAQ: FLYE) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Fly-E investors who were adversely affe ...

Accessibility StatementSkip Navigation NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Charter Communications, Inc. ("Charter Communications, Inc." or the "Company") (NASDAQ: CHTR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Charter Communications, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all persons and entities who purchased or otherwise acquired Chart ...

诉讼核心信息 - 律师事务所Levi & Korsinsky于2025年10月1日通知LifeMD Inc (NASDAQ: LFMD) 投资者有关一项证券集体诉讼 [1] - 该诉讼旨在为在2025年5月7日至2025年8月5日期间因涉嫌证券欺诈而遭受损失的LifeMD投资者挽回损失 [1] - 投资者申请作为首席原告的截止日期为2025年10月25日 [3] 诉讼指控细节 - 指控被告做出了虚假陈述和/或隐瞒了事实，即被告在实质上夸大了LifeMD的竞争地位 [2] - 指控被告在提高LifeMD 2025年业绩指引时是鲁莽的，因其未恰当核算RexMD业务部门不断上升的客户获取成本，以及与销售Wegovy和Zepbound等肥胖症治疗药物相关的客户获取成本 [2] - 因此，被告关于LifeMD业务、运营和前景的陈述在相关时间点均存在实质性的虚假和误导性，和/或缺乏合理依据 [2] 律师事务所背景 - Levi & Korsinsky律师事务所在过去20年间已为受损股东追回数亿美元，并在高风险诉讼中拥有胜诉记录 [4] - 该事务所在复杂证券诉讼中代表投资者方面拥有广泛专业知识，团队拥有超过70名员工 [4] - 该事务所已连续七年被ISS Securities Class Action Services评为美国顶级证券诉讼事务所之一 [4]

法律诉讼 - 律师事务所Levi & Korsinsky, LLP通知Cytokinetics公司的投资者有关一项证券集体诉讼 [1] - 诉讼旨在为在2023年12月27日至2025年5月6日期间因涉嫌证券欺诈而遭受不利影响的投资者挽回损失 [1]

Accessibility StatementSkip Navigation NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Novo Nordisk A/S ("Novo" or the "Company") (NYSE: NVO) of a class action securities lawsuit. NVO investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500. CASE DETAILS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and mislea ...

诉讼概述 - Levi & Korsinsky律师事务所于2025年10月1日通知RCI Hospitality Holdings, Inc (NASDAQ: RICK)的投资者，有一项集体诉讼证券诉讼已提起 [1] - 该诉讼旨在为在2021年12月15日至2025年9月16日期间因涉嫌证券欺诈而遭受不利影响的投资者挽回损失 [2] - 投资者若在此期间遭受损失，可在2025年11月20日前请求法院指定其为首席原告 [4] 诉讼指控细节 - 指控被告做出虚假陈述和/或隐瞒事实，包括被告从事税务欺诈 [3] - 指控被告通过行贿来掩盖其税务欺诈行为 [3] - 因此，被告低估了公司面临的法律风险，其关于业务、运营和前景的陈述在所有相关时间均存在重大虚假和误导性且/或缺乏合理依据 [3] 律师事务所信息 - Levi & Korsinsky律师事务所在过去20年间已为受损股东追回数亿美元，拥有处理高风险案件的记录 [5] - 该事务所在代表投资者处理复杂证券诉讼方面拥有广泛专业知识，团队拥有超过70名员工 [5] - 该事务所已连续七年被ISS Securities Class Action Services评为美国顶级证券诉讼事务所之一 [5]

Accessibility StatementSkip Navigation NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Fluor Corporation ("Fluor Corporation" or the "Company") (NYSE: FLR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Fluor Corporation investors who were adversely affected by alleged securities fraud between February 18, 2025 and July 31, 2025. Follow the link below to get more information and be contacted by a member of our team: ...

Accessibility StatementSkip Navigation NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Altimmune, Inc. ("Altimmune" or the "Company") (NASDAQ: ALT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Altimmune investors who were adversely affected by alleged securities fraud between August 10, 2023 and June 25, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/p ...

LEHI, Utah, and LOUISVILLE, Ky., Oct. 1, 2025 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced the successful completion of its acquisition of Iodine Software ("Iodine"). The combination of one of the industry's largest financial datasets with one of the largest clinical datasets strengthens Waystar's AI platform to deliver transformational outcomes for healthcare providers while creating meaningful value for shareholders. Iodine's clie ...

Accessibility StatementSkip Navigation NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, highlighted its recent series of sponsored physician training programs hosted at premier U.S. academic medical centers. Over the past several months, these intensive, hands-on courses at Tulane University and Columbia University have advanced the clinical proficiency o ...